Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ALETHEA CAPITAL MANAGEMENT, LLC

Q1 2025 · 13F-HR

ALETHEA CAPITAL MANAGEMENT, LLCholdings as filed

Filed 2025-05-14 · accession 0001549408-25-000006

$134.0M
Reported value
11
Positions
2025-03-31
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
05464T104AXSMAXSOME THERAPEUTICS INC$77.8M58.1%667,368CommonSOLE
78468R663BILSPDR SER TR$28.1M20.9%306,042CommonSOLE
05370A108RNAGBPAVIDITY BIOSCIENCES INC$12.4M9.29%421,724CommonSOLE
78462F103SPYSPDR S&P 500 ETF TR$8.4M6.25%14,970CommonSOLE
50127T109KURAKURA ONCOLOGY INC$4.4M3.25%659,177CommonSOLE
464287432TLTISHARES TR$2.1M1.57%23,123CommonSOLE
97717X701HEDJWISDOMTREE TR$376,2790.28%7,925CommonSOLE
171757206CDTXCIDARA THERAPEUTICS INC$308,2590.23%14,311CommonSOLE
27828A100XEVMXEATON VANCE CALIF MUN BD FD$98,8000.07%10,658CommonSOLE
68373J104LPROOPEN LENDING CORP$33,1200.02%12,000CommonSOLE
876511106TGBTASEKO MINES LTD$22,4000.02%10,000CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.